MLM Ranks

LifeVantage Q3 Fiscal 2026 Results Report

LifeVantage Reports Third Quarter Fiscal 2026 Financial Results

LifeVantage Corporation (Nasdaq: LFVN) released its financial results for the third quarter of fiscal 2026, ended March 31, 2026. The company continues to focus on expense management, share repurchases, and long-term growth in the health and wellness sector despite a challenging quarter.

Third Quarter Fiscal 2026 Key Highlights

  • Revenue: $43.7 million (down 25.2% year-over-year)

  • Americas Revenue: decreased 28.9%

  • Asia/Pacific & Europe Revenue: decreased 7.7%

  • Net Income per Diluted Share: $0.11 (vs. $0.26 last year)

  • Adjusted EPS: $0.12 (vs. $0.26 last year)

  • Adjusted EBITDA: $3.2 million (vs. $6.4 million last year)
Professional portrait of Michael Beindorff, Interim CEO of LifeVantage, wearing a black suit and pink tie.

CEO Statement

Michael Beindorff, Interim CEO of LifeVantage, commented:

“Third quarter results were softer than we anticipated as lower sales of our MindBody GLP-1 System® were only partially offset by the addition of LoveBiome. Despite top-line headwinds, we stayed disciplined with expenses and capital allocation, allowing us to continue repurchasing shares while keeping a strong balance sheet. We are not satisfied with our performance and are fully focused on the changes needed to drive better results going forward. With our science-backed nutrigenomics approach, strong product portfolio, passionate consultants, and solid financial foundation, LifeVantage is well positioned for future growth in the expanding wellness market.”

Quarterly Performance Overview

Total revenue for the quarter was $43.7 million compared to $58.4 million in the same period last year. The decline was mainly driven by lower sales of the MindBody GLP-1 System® in the Americas, partially offset by contributions from LoveBiome, which was acquired in October 2025.

Gross margin was 79.0% (adjusted 79.4% excluding one-time inventory allowance). The company maintained strong cost control, with commissions and incentives at 43.5% of revenue. Operating income stood at $1.7 million, with Adjusted EBITDA of $3.2 million.

LifeVantage remains committed to its core strengths in nutrigenomics and cellular health while integrating new products to support future revenue growth.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN) is a pioneer in nutrigenomics. The company develops science-backed products that activate the body’s natural processes for optimal health at the cellular level. Its flagship product lines include Protandim®, TrueScience® skincare, MindBody GLP-1 System®, LoveBiome P84, and AXIO® energy drinks. LifeVantage products are sold through independent Consultants across multiple markets. The company is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.

RELATED ARTICLES

Reviews:

There are no reviews yet. Be the first one to write one.

Leave Your Review Here:

MLM Ranks YouTube channel disclaimer outlining general info, no financial advice, earnings disclaimer, and copyright notice.